Plain-English translation of NCT03846297 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hypertrophic Cardiomyopathy research guide →This study is gathering information from 2,000 patients with hypertrophic cardiomyopathy—a genetic condition where the heart muscle becomes thickened—to help doctors make better decisions about who needs an implantable defibrillator (a small device that prevents life-threatening heart rhythms). Right now, different countries and medical organizations have conflicting guidelines about which patients should receive this device, and most of those guidelines are based on older research. This study will collect real-world patient data to create updated, evidence-based recommendations that are consistent worldwide.
Hypertrophic cardiomyopathy can cause sudden cardiac death, especially in young people and athletes, and an implantable defibrillator is the most reliable way to prevent this. However, doctors currently disagree about which patients truly need the device because the existing guidelines are based on limited data and vary between countries. This study exists to gather comprehensive information that will help create clearer, more consistent guidance so the right patients get protected without unnecessary procedures.
You likely qualify if…
You likely don't qualify if…
You would visit your heart doctor at one of 40 participating centers and allow researchers to collect information from your medical records and routine care. You would give one extra blood sample at your first visit and complete a short interview each year during follow-up. No special procedures or treatments are required—the study simply observes and documents your normal medical care to better understand which patients benefit most from heart device implants.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
France